[1. Pearlstein TB, Frank E, Rivera-Tovar A, Thoft JS, Jacobs E, Mieczkowski TA. Prevalence of axis I and axis II disorders in women with late luteal phase dysphoric disorder. J Affect Disord. 1990;20(2):129-34.10.1016/0165-0327(90)90126-S]Search in Google Scholar
[2. Chandraiah S, Levenson JL, Collins JB. Sexual dysfunction, social maladjustment, and psychiatric disorders in women seeking treatment in a premenstrual syndrome clinic. Int J Psychiatry Med. 1991;21(2):189-204.10.2190/A4JM-PGR9-35PH-4WCW]Search in Google Scholar
[3. Stout AL, Steege JF, Blazer DG, George LK. Comparison of lifetime psychiatric diagnoses in Premenstrual Syndrome Clinic and community samples. J Nerv Ment Dis. 1986;174(9):517-22.10.1097/00005053-198609000-00002]Search in Google Scholar
[4. Harrison WM, Endicott J, Nee J, Glick H, Rabkin JG. Characteristics of women seeking treatment for premenstrual syndrome. Psychosomatics. 1989;30(4):405-11.10.1016/S0033-3182(89)72246-5]Search in Google Scholar
[5. Fava M, Pedrazzi F, Guaraldi GP, Romano J, Genazzani AR, Facchinett F. Comorbid anxiety and depression among patients with late luteal phase dysphoric disorder. J Anx Disord. 1992;6(4):325-35.10.1016/0887-6185(92)90004-Q]Search in Google Scholar
[6. Cameron OG, Kuttesch D, McPhee K, Curtis GC. Menstrual fluctuation in the symptoms of panic anxiety. J Affect Disord. 1988;15:169-74.10.1016/0165-0327(88)90086-9]Search in Google Scholar
[7. Cook BL, Noyes R, Garvey MJ, Beach V, Sobotka J, Chaudhry D. Anxiety and the menstrual cycle in panic disorder. J Affect Disord. 1990;19(3):221-6.10.1016/0165-0327(90)90095-P]Search in Google Scholar
[8. Stein MB, Schmidt PJ, Rubinow DR, Uhde TW. Panic disorder and the menstrual cycle: panic disorder patients, healthy control subjects, and patients with premenstrual syndrome. Am J Psychiatry. 1989;146(10):1299-303.10.1176/ajp.146.10.1299]Search in Google Scholar
[9. Kaspi S, Otto MW, Pollack MH, Eppinger S, Rosenbaum JF. Premenstrual exacerbation of symptoms in women with panic disorder. J Anx Disord. 1994;8(2):131-8.10.1016/0887-6185(94)90011-6]Search in Google Scholar
[10. Vickers K, McNally RJ. Is premenstrual dysphoria a variant of panic disorder? A review. Clin Psychol Rev. 2004;24(8):933-56.10.1016/S0272-7358(04)00102-3]Search in Google Scholar
[11. Le Melledo JM, Bradwejn J, Koszycki D, Bichet D. Premenstrual dysphoric disorder and response to cholecystokinin-tetrapeptide. Arch Gen Psychiatry. 1995;52(7):605-6.10.1001/archpsyc.1995.03950190087012]Search in Google Scholar
[12. Le Melledo J, Van Driel M, Coupland NJ, Lott P, Jhangri GS. Response to flumazenil in women with premenstrual dysphoric disorder. Am J Psychiatry. 2000;157(5):821-3.10.1176/appi.ajp.157.5.821]Search in Google Scholar
[13. Adewuya AO, Loto OM, Adewumi TA. Premenstrual dysphoric disorder amongst Nigerian university students: prevalence, comorbid conditions, and correlates. Arch Womens Ment Health. 2008;11(1):13-8.10.1007/s00737-008-0213-4]Search in Google Scholar
[14. Schwartz GE, Goetz RR, Klein DF, Endicott J, Gorman JM. Tidal volume of respiration and “sighing” as indicators of breathing irregularities in panic disorder patients. Anxiety. 1996;2(3):145-8.10.1002/(SICI)1522-7154(1996)2:3<145::AID-ANXI6>3.0.CO;2-O]Search in Google Scholar
[15. Harrison WM, Sandberg D, Gorman JM, Fyer M, Nee J, Uy J, et al. Provocation of panic with carbon dioxide inhalation in patients with premenstrual dysphoria. Psychiatry Res. 1989;27(2):183-92.10.1016/0165-1781(89)90133-9]Search in Google Scholar
[16. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini International Neuropsychiatric Interview (M.i.N.i.): the development and validation of structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20):22-33.]Search in Google Scholar
[17. Steiner M, Macdougall M, Brown E. The premenstrual symptoms screening tool (PSST) for clinicians. Arch Womens Ment Health. 2003;6(3):203-9.10.1007/s00737-003-0018-4]Search in Google Scholar
[18. Matsumoto TH, Asakura T, Hayashi T. Biopsychosocial aspects of premenstrual syndrome and premenstrual dysphoric disorder. Gynecol Endocrinol. 2013;29(1):67-73.10.3109/09513590.2012.705383]Search in Google Scholar
[19. Miyaoka Y, Akimoto Y, Ueda K, Ujiie Y, Kametani M, Uchiide Y, et al. Fulfillment of the premenstrual dysphoric disorder criteria confirmed using a self-rating questionnaire among Japanese women with depressive disorders. Biopsychosoc Med. 2011 2;5:5.10.1186/1751-0759-5-5]Search in Google Scholar
[20. Cohen LS, Soares CN, Otto MW, Sweeney BH, Liberman RF, Harlow BL. Prevalence and predictors of premenstrual dysphoric disorder (PMDD) in older premenopausal women. The Harvard Study of Moods and Cycles. J Affect Disord. 2002;70(2):125-32.10.1016/S0165-0327(01)00458-X]Search in Google Scholar
[21. Sehlo MG, Youssef UM, Mahdy RS, El-Gohari H. Prevalence and symptoms of premenstrual dysphoric disorder in a sample of psychiatric patients at Zagazig University Hospitals. Egypt J Psychiatry. 2018;39(2):83-8.10.4103/ejpsy.ejpsy_36_17]Search in Google Scholar
[22. Halbreich U, O’Brien PM, Eriksson E, Backstrom T, Yonkers KA, Freeman EW. Are there differential symptom profiles that improve in response to different pharmacological treatments of premenstrual syndrome/premenstrual dysphoric disorder? CNS Drugs. 2006;20(7):523-47.10.2165/00023210-200620070-00001]Search in Google Scholar
[23. Kim DR, Gyulai L, Freeman EW, Morrison ME, Baldassano C, Dube B. Premenstrual dysphoric disorder and psychiatric co-morbidity. Arch Womens Ment Health. 2004;7(1):37-47.10.1007/s00737-003-0027-3]Search in Google Scholar
[24. Breaux C, Hartlage S, Gehlert S. Relationships of premenstrual dysphoric disorder to major depression and anxiety disorders: a re-examination. J Psychosom Obstet Gynecol. 2000;21(1):17-24.10.3109/01674820009075604]Search in Google Scholar
[25. Yonkers KA, Halbreich U, Freeman E, Brown C, Endicott J, Frank E, et al. Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. a randomized controlled trial. Sertraline Premenstrual Dysphoric Collaborative Study Group. JAMA. 1997;278(12):983-8.10.1001/jama.1997.03550120043031]Search in Google Scholar
[26. Landen M, Nissbrandt H, Allgulander C, Sörvik K, Ysander C, Eriksson E. Placebo-controlled trial comparing intermittent and continuous paroxetine in premenstrual dysphoric disorder. Neuropsychopharmacology. 2007;32(1):153-61.10.1038/sj.npp.1301216]Search in Google Scholar
[27. Steiner M, Pearlstein T, Cohen LS, Endicott J, Kornstein SG, Roberts C, et al. Expert guidelines for the treatment of severe PMS, PMDD, and comorbidities: the role of SSRis. J Womens Health (Larchmt). 2006;15(1):57-69.10.1089/jwh.2006.15.57]Search in Google Scholar
[28. Steiner M, Romano SJ, Babcock S, Dillon J, Shuler C, Berger C, et al. The efficacy of fluoxetine in improving physical symptoms associated with premenstrual dysphoric disorder. BJOG. 2001;108(5):462-8.10.1111/j.1471-0528.2001.00120.x]Search in Google Scholar
[29. Dimmock PW, Wyatt KM, Jones PW, O’Brien PM. Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome : asystematic review. The Lancet. 2000;356(9236):1131-6.10.1016/S0140-6736(00)02754-9]Search in Google Scholar
[30. O’Brien PM, BackstromT, Brown C, Dennerstein L, Endicott J, Epperson CN, et al. Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: the ISPMD Montreal consensus. Arch Womens Ment Health. 2011;14(1):13-21.10.1007/s00737-010-0201-3413492821225438]Search in Google Scholar
[31. Walsh S, Ismaili E, Naheed B, O’Brien S. Diagnosis, pathophysiology and management of premenstrual syndrome. Obstet Gynaecol. 2015;17:99-104.10.1111/tog.12180]Search in Google Scholar
[32. Marjoribanks J, Brown J, O’Brien PM, Wyatt K. Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database Syst Rev. 2013;7(6):CD001396.10.1002/14651858.CD001396.pub3707341723744611]Search in Google Scholar